J&J Unit Escapes FCA Case Over Alleged Procrit Kickbacks
By Jeff Overley ( August 14, 2012, 1:25 PM EDT) -- A biotechnology unit of Johnson & Johnson on Monday dispensed with the remnants of a False Claims Act case alleging kickbacks to doctors who prescribed anemia drug Procrit after the relator conceded she lacked evidence to support the few allegations left intact after years of litigation....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.